Impact of the anti-inflammatory agent bindarit on the chemokinome: Selective inhibition of the monocyte chemotactic proteins

European Cytokine Network

Volumn 19, Issue 3, 2008, Pages 119-122

  Mirolo, Massimiliano ^a   Fabbri, Marco ^a   Sironi, Marina ^a   Vecchi, Annunciata ^a   Guglielmotti, Angelo ^b   Mangano, Giorgina ^b   Biondi, Giuseppe ^b   Locati, Massimo ^a,c   Mantovani, Alberto ^a,c  

^a HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^b Università Politecnica delle Marche ACRAF Gruppo Angelini   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

Author keywords

Chemokines; Gene regulation; Inflammation; Lipopolysaccharide

Indexed keywords

ANTIINFLAMMATORY AGENT; BINDARIT; MONOCYTE CHEMOTACTIC PROTEIN 1; MONOCYTE CHEMOTACTIC PROTEIN 2; MONOCYTE CHEMOTACTIC PROTEIN 3; UNCLASSIFIED DRUG; INDAZOLE DERIVATIVE; MONOCYTE CHEMOTACTIC PROTEIN; PROPIONIC ACID DERIVATIVE;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; MONOCYTE; CELL CULTURE; CYTOLOGY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETICS; METABOLISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANTI-INFLAMMATORY AGENTS; CELLS, CULTURED; CHEMOKINE CCL2; CHEMOKINE CCL7; CHEMOKINE CCL8; ENDOTHELIAL CELLS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; INDAZOLES; MONOCYTE CHEMOATTRACTANT PROTEINS; MONOCYTES; PROPIONIC ACIDS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 58149390072     PISSN: 11485493     EISSN: None     Source Type: Journal    
DOI: 10.1684/ecn.2008.0133     Document Type: Article

References (17)

1. Akira SS, Uematsu O. Takeuchi. Pathogen recognition and innate immunity. Cell 2006; 124: 783-801.
2. O'Neill LA. How Toll-like receptors signal: what we know and what we don't know. Curr Opin Immunol 2006; 18: 3-9.
3. Charo IF, Ransohoff RM. The many roles of chemokines and chemokine receptors in inflammation. NEnglJMed 2006; 354: 610-21.
4. Allegretti M, Bertini R, Bizzarri C, et al. Allosteric inhibitors of chemoattractant receptors: opportunities and pitfalls. Trends Pharmacol Sci 2008; 29: 280-6.
5. Guglielmotti A, Aquilini L, D'Onofrio E, et al. Bindarit prolongs survival and reduces renal damage in NZB/W lupus mice. Clin Exp Rheumatol 1998; 16: 149-54.
6. Guglielmotti A, D'Onofrio E, Coletta I, et al. Amelioration of rat adjuvant arthritis by therapeutic treatment with bindarit, an inhibitor of MCP-1 and TNF-alpha production. Inflamm Res 2002; 51: 252-8.
7. Zoja C, Corna D, Benedetti G, et al. Bindarit retards renal disease and prolongs survival in murine lupus autoimmune disease. Kidney Int 1998; 53: 726-34.
8. Sironi M, Guglielmotti A, Polentarutti N, et al. A small synthetic molecule capable of preferentially inhibiting the production of the CC chemokine monocyte chemotactic protein-1. Eur Cytokine Netw 1999; 10: 437-42.
9. Murphy PM. The molecular biology of leukocyte chemoattractant receptors. Annu Rev Immunol 1994; 12: 593-633.
10. Perrier PF, Martinez O, Locati M, et al. Distinct transcriptional programs activated by interleukin-10 with or without lipopolysac- charide in dendritic cells: induction of the B cell-activating chemokine, CXC chemokine ligand 13. J Immunol 2004; 172: 7031-42.
11. Allavena P, Paganin C, Martin-Padura I, et al. Molecules and structures involved in the adhesion of natural killer cells to vascular endothelium. J Exp Med 1991; 173: 439-48.
12. Martinez FO, Gordon S, Locati M, et al. Transcriptional profiling of the human monocyte-to-macrophage differentiation and polarization: new molecules and patterns of gene expression. J Immunol 2006; 177: 7303-11.
13. Van Coillie E, Van Damme J, Opdenakker G. The MCP/eotaxin subfamily of CC chemokines. Cytokine Growth Factor Rev 1999; 10: 61-86.
14. Bhatia M, Ramnath RD, Chevali L, et al. Treatment with bindarit, a blocker of MCP-1 synthesis, protects mice against acute pancreatitis. Am J Physiol Gastrointest Liver Physiol 2005; 288: G1259- G1265.
15. Cioli V, Ciarniello MG, Guglielmotti A, et al. A new protein anti- denaturant agent, bindarit, reduces secondary phase of adjuvant arthritis in rats. J Rheumatol 1992; 19: 1735-42.
16. Guglielmotti A, Silvestrini B, Saso L, et al. Chronic inflammatory response in the rat can be blocked by bindarit. Biochem Mol Biol Int 1993; 29: 747-56.
17. Viola A, Luster AD. Chemokines and their receptors: drug targets in immunity and inflammation. Annu Rev Pharmacol Toxicol 2008; 48: 171-97.